Elliot Offman

704 total citations
33 papers, 505 citations indexed

About

Elliot Offman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Elliot Offman has authored 33 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Physiology. Recurrent topics in Elliot Offman's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Fatty Acid Research and Health (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Elliot Offman is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Fatty Acid Research and Health (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Elliot Offman collaborates with scholars based in United States, Canada and Sweden. Elliot Offman's co-authors include Andrea N. Edginton, Michael H. Davidson, John Messina, Ramy Mahmoud, Douglas Kling, Jennifer Carothers, Sandy Ferber, Judith Johnson, Danielle Curcio and Per G. Djupesland and has published in prestigious journals such as Gastroenterology, Neurology and CHEST Journal.

In The Last Decade

Elliot Offman

33 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elliot Offman United States	14	132	98	72	71	71	33	505
Jeong Seok Hwa South Korea	13	343 2.6×	103 1.1×	67 0.9×	79 1.1×	82 1.2×	45	769
In Jin Kim South Korea	15	199 1.5×	96 1.0×	64 0.9×	52 0.7×	40 0.6×	31	648
Nadica Matevska-Geshkovska North Macedonia	13	247 1.9×	48 0.5×	85 1.2×	36 0.5×	36 0.5×	33	531
Paraskevi Savvari Greece	12	271 2.1×	175 1.8×	43 0.6×	111 1.6×	85 1.2×	20	1.1k
M Iappelli Italy	15	104 0.8×	72 0.7×	64 0.9×	326 4.6×	47 0.7×	41	810
Jin Young Jeong South Korea	14	225 1.7×	73 0.7×	38 0.5×	155 2.2×	95 1.3×	29	778
Carole Richard France	13	208 1.6×	51 0.5×	60 0.8×	72 1.0×	78 1.1×	32	818
Weizhong Zhang China	12	288 2.2×	62 0.6×	68 0.9×	90 1.3×	26 0.4×	37	921
Tadashi Imafuku Japan	15	278 2.1×	42 0.4×	68 0.9×	95 1.3×	244 3.4×	36	783

Countries citing papers authored by Elliot Offman

Since Specialization

Citations

This map shows the geographic impact of Elliot Offman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elliot Offman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elliot Offman more than expected).

Fields of papers citing papers by Elliot Offman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elliot Offman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elliot Offman. The network helps show where Elliot Offman may publish in the future.

Co-authorship network of co-authors of Elliot Offman

This figure shows the co-authorship network connecting the top 25 collaborators of Elliot Offman. A scholar is included among the top collaborators of Elliot Offman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elliot Offman. Elliot Offman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosenstock, Moti, Leo Tseng, Andrew L. Pierce, et al.. (2023). The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human Volunteers. Journal of Pharmacology and Experimental Therapeutics. 387(2). 204–213. 16 indexed citations

Howden, Colin W., Shailja C. Shah, Salil N. Pendse, et al.. (2023). Physiologically‐based pharmacokinetic modelling to predict intragastric rifabutin concentrations in the treatment of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 58(2). 159–167. 7 indexed citations

Offman, Elliot, M Julián, Landon W. Locke, et al.. (2023). Leveraging in vitro and pharmacokinetic models to support bench to bedside investigation of XTMAB-16 as a novel pulmonary sarcoidosis treatment. Frontiers in Pharmacology. 14. 1066454–1066454. 7 indexed citations

Gupta, Neeraj, Xiaohui Wang, Elliot Offman, et al.. (2020). Population Pharmacokinetics of Brigatinib in Healthy Volunteers and Patients With Cancer. Clinical Pharmacokinetics. 60(2). 235–247. 15 indexed citations

Gupta, Neeraj, Xiaohui Wang, Elliot Offman, et al.. (2020). Brigatinib Dose Rationale in Anaplastic Lymphoma Kinase–Positive Non‐Small Cell Lung Cancer: Exposure–Response Analyses of Pivotal ALTA Study. CPT Pharmacometrics & Systems Pharmacology. 9(12). 718–730. 14 indexed citations

Stamler, David, Margaret Bradbury, Cynthia S. Wong, & Elliot Offman. (2019). A First in Human Study of PBT434, a Novel Small Molecule Inhibitor of α-Synuclein Aggregation (S4.001). Neurology. 92(15_supplement). 13 indexed citations

Graham, David Y., Saleh A. Naser, Elliot Offman, et al.. (2019). 643 RHB-104, a Fixed-Dose, Oral Antibiotic Combination Against Mycobacterium Avium Paratuberculosis (MAP) Infection, Is Effective in Moderately to Severely Active Crohn's Disease. The American Journal of Gastroenterology. 114(1). S376–S377. 14 indexed citations

Messina, John, et al.. (2019). A Randomized Comparison of the Pharmacokinetics and Bioavailability of Fluticasone Propionate Delivered via Xhance Exhalation Delivery System Versus Flonase Nasal Spray and Flovent HFA Inhalational Aerosol. Clinical Therapeutics. 41(11). 2343–2356. 9 indexed citations

Offman, Elliot, Michael H. Davidson, & Catarina Nilsson. (2017). No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers. American Journal of Cardiovascular Drugs. 17(3). 251–260. 2 indexed citations

10.

Offman, Elliot, Michael H. Davidson, & Catarina Nilsson. (2017). Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers. Journal of clinical lipidology. 11(3). 739–748. 2 indexed citations

11.

Stamler, David, et al.. (2016). A Relative Bioavailability Study of Three Dose Strengths and Four Dose Levels of SD-809, a Potential Treatment for Movement Disorders (P1.054). Neurology. 86(16_supplement). 3 indexed citations

12.

Nguyen, Linh Thuy, et al.. (2016). Pharmacokinetics of cabozantinib tablet and capsule formulations in healthy adults. Anti-Cancer Drugs. 27(7). 669–678. 45 indexed citations

13.

Munjal, Sagar, et al.. (2016). A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN‐02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults. Headache The Journal of Head and Face Pain. 56(9). 1455–1465. 26 indexed citations

14.

Paglialunga, Sabina, et al.. (2016). Update and trends on pharmacokinetic studies in patients with impaired renal function: practical insight into application of the FDA and EMA guidelines. Expert Review of Clinical Pharmacology. 10(3). 1–11. 22 indexed citations

15.

Offman, Elliot, Colin Phipps, & Andrea N. Edginton. (2016). Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide. In Silico Pharmacology. 4(1). 3–3. 14 indexed citations

16.

Offman, Elliot & Andrea N. Edginton. (2015). A PBPK workflow for first-in-human dose selection of a subcutaneously administered pegylated peptide. Journal of Pharmacokinetics and Pharmacodynamics. 42(2). 135–150. 18 indexed citations

17.

Offman, Elliot, et al.. (2013). Improved Pharmacokinetics of Sumatriptan With B reath P owered™ Nasal Delivery of Sumatriptan Powder. Headache The Journal of Head and Face Pain. 53(8). 1323–1333. 52 indexed citations

18.

Offman, Elliot, et al.. (2013). Pharmacokinetics and Pharmacodynamics of the Antiplatelet Combination Aspirin (Acetylsalicylic Acid) Plus Extended-Release Dipyridamole Are Not Altered by Coadministration with the Potent CYP2C19 Inhibitor Omeprazole. American Journal of Cardiovascular Drugs. 13(2). 113–120. 6 indexed citations

19.

Offman, Elliot, Sandy Ferber, Judith Johnson, et al.. (2013). Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study. Vascular Health and Risk Management. 9. 563–563. 71 indexed citations

20.

Offman, Elliot & Andrea N. Edginton. (2012). Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development. Xenobiotica. 43(6). 561–569. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact